Company Overview and News
Dollar Tree, Inc. (DLTR - Free Report) announced plans to shutter Family Dollar’s Matthews, NC headquarters by next fall. Simultaneously, it will consolidate Family Dollar’s store support centers in Matthews and Chesapeake, VA into its recently completed 12-story — a 510,000 square foot office tower in Chesapeake — as part of the integration of Family Dollar that was acquired in 2015. However, Family Dollar's distribution center in Matthews will remain open following the consolidation.
DLTR TJX TGT BURL
Shares of Office Depot, Inc. (ODP - Free Report) have surged roughly 46% in the past six months. This Zacks Rank #2 (Buy) stock has not only fared better than the industry that increased 21% but also the Zacks Retail & Wholesale Sector that advanced about 8%. The company’s business operating model, growth prospects and omni-channel capabilities have definitely acted as propellants. The company is trying all means to give itself a complete makeover in an environment where demand for office products (paper-based) has shrunk due to technological advancements.
TGT BURL ODP URBN
Chicago, IL – September 19, 2018 – Zacks Equity Research highlights Microsoft (MSFT - Free Report) as the Bull of the Day, MercadoLibre (MELI - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Target Corp. (TGT - Free Report) , Burlington Stores, Inc. (BURL - Free Report) and The TJX Companies, Inc. (TJX - Free Report) .
RYAM BURL ESE ON CVTI UNFI TJX TGT GTS MSFT MELI INT TSC
Kirkland's, Inc.’s (KIRK - Free Report) shares have been on losing grounds, lately. Shares of this Zacks Rank #4 (Sell) company have plunged 27% in the past three months compared with the industry’s decline of 5.2%. Well, this retailer of home decor products has been biting the bullet due to comparable store sales (comps) decline, higher operating expenses and gross margin weakness. Higher Costs a Worry for Kirkland's Persistent weakness in gross margin is one of the major deterrents for Kirkland's performance.
KIRK TGT BURL TXN MDPEB URBN MDP
There seems to be a lot of cheer in the Retail – Discount Stores industry that has surged close to 46% in a year’s time, with quite a few companies cutting a promising figure. The industry, which comfortably crushed the S&P 500’s rise of almost 19%, is riding on strategic endeavors by companies and a flattering economic scenario. The economic landscape is being shaped by a strong labor market, improving consumer sentiment and benefits from tax reforms.
TJX TGT BURL TXN MDPEB MDP
Shares of Ollie's Bargain Outlet Holdings, Inc. (OLLI - Free Report) have surged roughly 50.6% in the past six months. This Zacks Rank #2 (Buy) stock has not only fared better than the industry that increased a meager 2.3% but also the Zacks Consumer Staples sector that fell 4.1%. Notably, shares of this Harrisburg, PA-based company are hovering near its 52-week high of $94.70, and there is no doubt why Ollie's Bargain cannot breach that mark in the near term.
OLLI TGT BURL TXN MDPEB URBN MDP
Last Thursday, Target Corp. (NYSE: TGT) announced plans to hire 120,000 seasonal workers to get the company through the 2018 holiday shopping season. That ties the single largest seasonal hiring plan ever announced, equal to last’s year’s total of 120,000 seasonal jobs at Amazon.com Inc. (NASDAQ: AMZN).
TGT BURL UPS AMZN BONTQ FDX M LB BONT
U.S. retail sales showed continued rise going into August but the rate of growth fairly moderated, as bargain hunters took a breather after an extravagant July. As Americans refrained from splurging on automobiles and apparel, retail sales showed a slight uptick in six months. Analysts also cited high gasoline prices as one of the prominent reasons behind soft sales in other categories. Nevertheless, an upwardly revised July sales data suggests that the economy is firm, given solid labor market, tax reform and rising income.
TGT BURL DSW DRI URBN
Investors focused on the Retail-Wholesale space have likely heard of Burlington Stores (BURL - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Retail-Wholesale peers, we might be able to answer that question.
L Brands, Inc. (LB - Free Report) recently revealed intentions to close all 23 Henri Bendel stores as well as Henri Bendel e-commerce website. Management hinted that the move is aimed at improving the company’s performance and creating shareholders’ value. The company’s store closure plan includes Fifth Avenue and smaller-format stores in 11 states. The company also informed that Henri Bendel brand is likely to generate revenues worth approximately $85 million, while it is expected to incur operating loss of roughly $45 million in fiscal 2018.
TGT BURL LB URBN VCP
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction.
Chicago, IL – September 13, 2018 – Zacks Market Edge is a podcast hosted weekly by cks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: (https://www.zacks.com/stock/news/322606/should-you-buy-the-superstar-retail-stocks)
BURL TCP VTNR SUMR HBIO
Gradual wage acceleration, steady job growth, improving consumer sentiment and sound economic fundamentals are working in tandem for the Retail – Discount Stores Industry. Additionally, the cut in corporate tax rate is allowing retailers to channelize the surplus money toward best possible alternatives. Further, an individual tax cut is freeing up disposable income, forming a firm foundation for higher consumption.
TJX TGT BURL COST
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to BURL / Burlington Stores, Inc. on message board site Silicon Investor.
|Burlington Nrth./Santa Fe (NYSE:BNI)||Burlington Nrth./Santa Fe (NYSE:BNI)||Burlington Nrth./Santa Fe (NYSE:BNI)||Burlington Resources (BR)||Burlington Resources (BR)||Burlington Resources (BR)|
as of ET